HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Studies of a C2 DNA polymorphism in RA, Felty's and normal subjects.

Abstract
A restriction fragment length polymorphism at the C2 locus was studied in rheumatoid arthritis (RA), Felty's and control subjects. No association was found between any C2 variant and either RA itself or within the rheumatoid population with Felty's syndrome. The C2 DNA polymorphism can be used to subdivide Bf*S- as well as Bf*F-bearing haplotypes. The 2.65-kb C2 DNA allele showed allelic association with HLA-B44 and C4B*Q0 and may help to further characterize the haplotype B44-Bf*S-C4A*3-C4B*Q0-DR4, which has previously been described in Felty's syndrome.
AuthorsR Clarkson, P A Sanders, D M Grennan
JournalExperimental and clinical immunogenetics (Exp Clin Immunogenet) Vol. 7 Issue 1 Pg. 64-8 ( 1990) ISSN: 0254-9670 [Print] Switzerland
PMID1971759 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Complement C2
  • HLA Antigens
  • HLA-DR4 Antigen
  • Complement C4a
  • Complement C4b
  • Complement Factor B
Topics
  • Alleles
  • Arthritis, Rheumatoid (blood, genetics)
  • Chi-Square Distribution
  • Complement C2 (genetics)
  • Complement C4a (genetics)
  • Complement C4b (genetics)
  • Complement Factor B (genetics)
  • Felty Syndrome (blood, genetics)
  • HLA Antigens (genetics)
  • HLA-DR4 Antigen (genetics)
  • Haplotypes
  • Humans
  • Major Histocompatibility Complex (genetics)
  • Polymorphism, Restriction Fragment Length

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: